Calcium sensing receptors (CaR) 1 are critically involved in regulating organismal mineral ion homeostasis (1) . Recent evidence suggests, however, that CaR regulates a variety of processes independent of Ca 2ϩ homeostasis, including secretion, cell proliferation and/or differentiation, apoptosis, and membrane excitability (2) (3) (4) . In brain, calcium sensing receptors are expressed, in a developmentally regulated manner, at substantial levels in the subfornical organ, olfactory bulbs, hippocampus, striatum, and cerebellum (5) (6) (7) (8) . CaR RNA and/or immunoreactivity has been identified in neurons, oligodendroglia, and microglia (8 -10) . In isolated hippocampal pyramidal neurons, CaR agonists activate non-selective cation and Ca 2ϩ -activated K ϩ channels (11) ; these responses are not observed when cells are isolated from mice having a targeted disruption of the CaR gene (12) . These studies suggest potential role(s) for CaR in modulating neuronal excitability, as well as local ion homeostasis in the brain. Interestingly, CaR expression in many brain regions overlaps with that established for group I metabotropic glutamate receptors (mGluRs) (13) (14) (15) (16) (17) and G␣ q / G␣ 11 (18) , the G protein implicated in mediating both CaR and group I mGluR activation of downstream signaling pathways.
CaR is a member of Family C of the G protein-coupled receptor superfamily, as are mGluRs, ␥-amino isobutyric acid receptors (GABA B Rs), and putative pheromone/taste receptors. CaR and mGluR1␣ are both activated by extracellular Ca 2ϩ over similar concentration ranges (19, 20) , although the mechanism(s) involved in Ca 2ϩ -mediated activation may differ (21) . Although CaR shares only a modest level of amino acid identity with mGluRs (Ͻ24%), critical structural similarities as well as overlapping agonist sensitivities hint at a common ancestry. In particular, CaR and Group I mGluRs have a large extracellular domain which incorporates both the agonist-binding site, sharing structural homology with bacterial periplasmic binding proteins and all other members of Family C (22) , and a cysteine-rich domain involved in signal transmission from the binding domain to the transmembrane helices (23) .
Both CaR and mGluRs function as disulfide-linked dimers (24 -28) . Recent studies on the structurally related GABA B Rs have shown that these receptors function only as heterodimers, incorporating GABA B1 and GABA B2 subunits (29 -31) . Chimeras of CaR and group I mGluRs are fully functional (32, 33) , suggesting that despite minimal sequence identity, the domains derived from distinct receptors can form productive interactions within the chimera. Given the overlapping expression of CaR and Group I mGluRs in brain, and their ability to form functional chimeras, we determined whether CaR and Group I mGluRs formed heterodimers in vivo. Here we demonstrate that heterodimers of these two distinct classes of G protein-coupled receptors form in vivo and in vitro, and demonstrate that trafficking of CaR within heterologously expressed CaR:mGluR heterodimers is influenced by glutamate and Homer 1c.
MATERIALS AND METHODS
Receptor Constructs-Human CaR (hCaR) was obtained from Dr. Klaus Seuwen (Novartis Pharma, AG, Basel, Switzerland), rat mGluR1␣ from Dr. Thomas P. Segerson (Oregon Health Sciences University), rat mGluR5 and Homer 1c from Dr. Paul Worley (Johns Hopkins University), ␤ 2 -adrenergic receptor from Dr. David Yue (Johns Hopkins University), and pDsRed1N1 was purchased from CLON-TECH. hCaR-EGFP was prepared as described (26) . Rat mGluR1␣ was subcloned from pBluescript into pCDNA3.1 (Invitrogen) with NotI. The mGluR1␣-EGFP construct was prepared by generating a polymerase chain reaction product containing a BamHI site in place of the stop codon, using the original mGluR1␣ in pBluescript as the template. After amplification, the product was cut with NotI-BamHI and subcloned in-frame into pEGFPN1 (CLONTECH). Double-tagged proteins (FlaghCaR-EGFP and Flag-mGluR1␣-EGFP) were generated by inserting the Flag TM epitope sequence in-frame after the respective signal peptides (MAFYSCCWVLLALTWHTSAYG for hCaR and MVRLLLIFFP-MIFLEMSILP for mGluR1␣) by inverse polymerase chain reaction (34), using hCaR-EGFP and mGluR1␣-EGFP as templates. The same technique was used to insert the Flag TM epitope sequence at the carboxyl termini of the wild type ␤ 2 -adrenergic receptor, mGluR1␣, mGluR5, and hCaR, to produce single epitope proteins.
Cell Transfection-Plasmids were introduced into HEK-293 cells by the liposomal formulation NovaFECTOR TM (Venn-Nova, Pompano Beach, FL) according to the manufacturer's protocol. A total of 2 g of plasmid mixture was diluted in Opti-MEM TM I (Life Technologies, Inc., Rockville, MD) and mixed with 5 l of transfection agent. When necessary, pDsRed1N1, which generates a soluble control protein, was used to maintain a constant amount of DNA (and protein expression) for each transfection.
Immunoprecipitation-Bovine brain was freshly obtained from a slaughterhouse and kept at 4°C in Hanks' balanced salt solution until dissection. Tissue was homogenized in lysis buffer (1 mM EDTA, 100 mM iodoacetamide, 0.5% Triton X-100 in PBS) containing protease inhibitors (Cømplete, Roche Molecular Biochemicals, Indianapolis, IN) using a Polytron homogenizer. After centrifugation at 20,000 rpm at 4°C, the supernatant was stored in 500-l aliquots at Ϫ80°C. Transfected HEK-293 cells were rinsed with PBS containing 1 mM EDTA, and after brief centrifugation at 500 rpm, the pellet was suspended in lysis buffer with protease inhibitors (as described above) and gently agitated at 4°C for 30 min. The tubes were centrifuged at 14,000 rpm for 10 min at 4°C and the supernatant was used for immunoprecipitation. To minimize nonspecific binding, 25 l of Protein G-Sepharose (Sigma), for ADD (monoclonal, obtained from Dr. A. Spiegel) and anti-Flag antibodies (Sigma) or Protein A-agarose (Invitrogen, Carlsbad, CA), for PA1-934 antibody (ABR, Golden, CO) was added to each tube (brain homogenate or transfected cells) and incubated for 1 h at 4°C. For immunoprecipitation from brain, 5 l of ADD (1 g/ml) or PA1-934 were added to each supernatant. For immunoprecipitation from transfected HEK-293 cells, 5 l of anti-Flag antibody (Sigma) was added to each supernatant and incubated for 2 h at 4°C. 25 l of resin (either Protein G-Sepharose or Protein A-agarose, depending upon the antibody) was added to each tube and incubated for 18 h at 4°C. The resin was washed 3 times with ice-cold wash buffer A (150 mM NaCl, 1% Triton X-100 in 50 mM Tris buffer) and incubated in 30 l of Western blot loading buffer (12 M urea, 4% SDS, 0.01% bromphenol blue, 100 mM ␤-mercaptoethanol in 200 mM Tris) for 30 min at room temperature. Samples were run on 4 -15% SDS-polyacrylamide gels as previously described (26) and blots probed with anti-GFP antibody at 1:2000 dilution (Molecular Probes, Eugene, OR).
ELISA-After 24 h of incubation at 37°C, transfected cells were replated into a 96-well plate pre-coated with rat tail collagen. Experiments were performed on the third day after transfection. Before experiments, cells were incubated with Dulbecco's modified Eagle's medium/zero glutamate for 4 h. Wells were treated with various agonists, and reactions were halted by fixing for 10 min at 22-24°C with 4% paraformaldehyde in PBS, rinsed twice with PBS, and blocked for 30 min with PBS, 5% fetal bovine serum. The blocking solution was replaced by 50 l of 1:4000 dilution of anti-Flag antibody (Sigma) conjugated with horseradish peroxidase. After 3 rinses with wash buffer B (0.5% Triton X-100 in PBS), the plate was developed with 50 l of 3,3Ј,5,5Ј-tetramethylbenzidine liquid substrate system (Sigma). After 20 -30 min, the substrate solutions from each well were transferred to a new plate containing 50 l of H 2 SO 4 (1 M). The plate was analyzed at 450 nm on a SpectraMAX 340 microplate reader (Molecular Devices Corp., Sunnyvale, CA). The original plate (containing the fixed cells) was washed 3 times with PBS, and then assayed for protein (Micro-BCA, Pierce, Rockford, IL) to permit normalization.
Immunofluorescence Localization-Fisher F344 rats (21, 28 , and 35 days of age, 5 rats per group) were deeply anesthetized with methoxyfluorane, and blood removed from tissues by intracardiac perfusion with 25 ml of cacodylate buffer, pH 7.4. Tissues were then fixed in situ by perfusion with 40 ml of 4% paraformaldehyde in cacodylate buffer. After 18 h post-fixation within the skull, the brains were dissected out and embedded in gelatin (15 brains per block). Serial 40-m thick cryostat sections were cut (Neuroscience Associates, Knoxville TN). Floating sections (5 sections per rat brain) were incubated with mild agitation in: 1) 0.05% Triton X-100 in PBS pH 7.4 (PBS-T) for 20 min; 2) 5% normal donkey serum (JacksonImmunoResearch Labs, Inc., West Grove, PA) in PBS (blocking solution) for 30 min; and 3) primary antibodies (10 g/ml, diluted in blocking solution) for 18 -48 h at room temperature. Primary antibodies were mouse monoclonal anti-CaR (ADD) and rabbit anti-mGluR1␣ (Chemicon Intl., Temecula, CA). Sections were then washed 3 times for 10 min with PBS-T before incubation with secondary conjugates (10 g/ml, diluted in blocking solution). Conjugates used were donkey anti-mouse IgG labeled with fluorescein and donkey anti-rabbit IgG labeled with rhodamine (JacksonImmunoResearch Labs, Inc.). Conjugate specificity was confirmed by abolition of detectable staining when the primary antibody was omitted. Sections were washed 3 times for 10 min with PBS-T, dipped in dH 2 O, and coverslipped with Vectashield (Vector Labs, Burlingame, CA), sealed with nail polish. Images were collected using a Zeiss LSM 510 confocal microscope using a 4-m optical slice and final magnification of ϫ 25-50.
RESULTS

Isolation of CaR:mGluR1␣ Heterodimers from HEK-293
Cells and Bovine Brain-Two different antibodies against CaR were used in immunoprecipitation studies from bovine brain. A monoclonal anti-CaR antibody, ADD, was obtained from Dr. Alan Spiegel (35) , and a polyclonal anti-CaR antibody, PA1-934, purchased from Affinity BioReagents. To confirm the specificity of both antibodies in immunoprecipitation studies, CaR-EGFP was heterologously expressed in HEK-293 cells, membranes solubilized, and immunoprecipitation performed with either ADD or PA1-934. Western blots were probed with anti-GFP antibody (Molecular Probes), and confirmed that both ADD and PA1-934 immunoprecipitated a band having a molecular mass appropriate to the GFP-tagged CaR (Ϸ190 kDa), Fig. 1A .
CaR, mGluR1␣, or CaR plus mGluR1␣ (1:1 cDNA ratio) were transiently expressed in HEK-293 cells, and immunoprecipitation was carried out with either ADD or PA1-934. Western blots were probed with anti-mGluR1␣ antibody (Chemicon), and as illustrated in Fig. 1B , only cells which had been transfected with both CaR and mGluR1␣ (lanes labeled C:G) yielded a band at the molecular mass consistent with mGluR1␣ (approximately 185 kDa). The anti-Flag antibody was used as a negative control for immunoprecipitation, and did not bring down mGluR1␣. These results clearly demonstrate that stable CaR:mGluR1␣ heterodimers form when heterologously expressed in HEK-293 cells. To determine whether CaR:mGluR heterodimers were formed in vivo, CaR from bovine brain was immunoprecipitated with either ADD or PA1-934. A third, control immunoprecipitation utilized the anti-Flag antibody. Western blots were probed with anti-mGluR1␣ antibodies (Fig.  1C ). Significant immunoreactivity was observed at a molecular weight consistent with fully glycosylated mGluR1 when immunoprecipitation was carried out with either ADD or PA1-934, but not when the anti-Flag antibody was used. The results illustrated in Fig. 1 indicate CaR:mGluR1 heterodimers form in vivo and in vitro.
Immunolocalization of CaR and mGluR1␣ in Rat Brain-To define the brain regions in which CaR:mGluR1␣ heterodimerization might be important, we performed immunofluorescence localization studies with the monoclonal anti-CaR antibody ADD and a rabbit polyclonal anti-mGluR1␣ antibody (Chemicon) in juvenile rat brain. We examined 3-5 serial brain sections from F344 rats at 21, 28, or 35 days of age (n ϭ 5 rats/age group). The immunoreactivity patterns observed for either receptor did not differ among these age groups. The expression patterns of both CaR and mGluR1␣ observed were consistent with previous studies (5, 36, 37) . Representative images from 28-day-old rats are shown in Fig. 2 .
The regions in which CaR and mGluR1␣ immunoreactivity were most highly expressed together were the cerebellum and the hippocampus. In the cerebellum, overlapping expression of CaR and mGluR1␣ was observed by confocal microscopy in cerebellar purkinje cells ( Fig. 2A, arrows) and molecular layer ( Fig. 2A, Ml) . Immunoreactivity for mGluR1␣ only was observed in the granule cell layer (Fig. 2A) . In the hippocampus, both CaR and mGluR1␣ immunoreactivity was observed in the dentate gyrus and polymorph layer of the dentate gyrus (Fig.  2B ) and CA3 region (not shown). CaR expression was also observed singly in hippocampal regions CA1 and CA2 (not shown), in isolated neurons in the brain stem (Fig. 2C ) and in fiber tracts of the brainstem and corpus callosum (not shown). These results indicate that both receptor proteins are present in the same cell location, and therefore are available to form CaR:mGluR1␣ heterodimers at specific locations in vivo.
In Vitro Characterization of CaR:mGluR1␣ Heterodimerization-The data in Figs. 1 and 2 strongly suggest that CaR and mGluR1␣ are co-localized, particularly in the hippocampus and cerebellum, and that they can be co-immunoprecipitated from brain homogenates. When heterologously expressed in the same cells, CaR and mGluR1␣ can also be co-immunoprecipitated. Further experiments were therefore designed to test the specificity of the association and nature of the interaction.
To determine the specificity of CaR interactions with Group I mGluRs, CaR-Flag was expressed in HEK-293 cells with various receptors tagged at their carboxyl termini with EGFP (CLONTECH). Membranes were isolated and CaR-Flag was immunoprecipitated with an anti-Flag antibody. Western blots of the immunoprecipitates were probed with an anti-GFP antibody to determine whether CaR-Flag interacted with the coexpressed receptors. The ␤ 2 -adrenergic receptor, from a distinct family of G protein-coupled receptors, was used as a negative control, and did not co-precipitate with CaR-Flag (Fig.  3A , B2:C). As a positive control, CaR-Flag and CaR-EGFP were co-expressed and co-precipitated with the anti-Flag antibody (Fig. 3A , C:C), as we have previously shown (26) . Finally, when CaR-Flag was co-expressed with either mGluR1␣-EGFP (G1:C) or mGluR5-EGFP (G5:C), significant GFP immunoreactivity was observed, suggesting an intimate interaction between CaR and Group I mGluRs, consistent with heterodimerization. Given the structural similarities between CaR and mGluRs, several additional controls for specificity were performed. CaRFlag was transfected into one population of HEK-293 cells, and mGluR1␣-EGFP, mGluR5-EGFP, or ␤ 2 -adrenergic receptor-EGFP were transfected into distinct populations of HEK-293 cells; membranes were isolated independently from each trans-
FIG. 1. CaR immunoprecipitates with mGluR1␣.
A, the specificity of two antibodies against CaR, ADD and PA1-934, was established by immunoprecipitation of CaR-EGFP transiently expressed in HEK-293 cells. Samples were run on 4 -15% SDS-polyacrylamide electrophoresis gels, and Western blots were probed with anti-GFP antibody. B, ADD co-immunoprecipitates CaR and mGluR1␣ from transfected cells. HEK-293 cells in 35-mm dishes were transfected with 2 g of CaR, mGluR1␣, or both (C:G). Cells were harvested, and solubilized membranes were immunoprecipitated with ADD, anti-Flag, or PA1-934 antibodies. Western blots were probed with anti-mGluR1␣ antibody. C, ADD co-immunoprecipitates CaR and mGluR1␣ from bovine thalamus. 1 ml of bovine thalamus homogenate (500 g/ml) was immunoprecipitated with ADD, anti-Flag, or PA1-934 antibodies. Samples were run on 4 -15% SDS-polyacrylamide gel electrophoresis, and blot was probed with anti-mGluR1␣ antibody. In all blots involving PA1-934, the intense band at 130 kDa is due to antibody.
FIG. 2.
CaR and mGluR1␣ are co-localized in juvenile rat brain. CaR and mGluR1␣ immunoreactivity was detected in serial brain sections from 28-day-old F344 rats (n ϭ 5). Confocal microscopy revealed co-localization (yellow) of CaR (green) and mGluR1␣ (red) in cerebellar Purkinje cells (A, arrows) and molecular layer, and in hippocampal dentate gyrus (B). CaR immunoreactivity alone is observed in neuronal cell bodies in the brain stem (C), and mGluR1␣ immunoreactivity alone detected in the cerebellar granular cell layer (A). The brain sections (40-m thick cryostat) were incubated with 10 g/ml mouse monoclonal anti-CaR and rabbit anti-mGluR1␣ for 36 h. Omission of the specific receptor antibodies abolished staining (not shown). Abbreviations: Ml, molecular layer; Gcl, granular cell layer; Pcl, Purkinje cell layer; DG, dentate gyrus; PoDG, polymorph layer dentate gyrus. Images were collected using a Zeiss LSM 510 confocal microscope using 4-m optical slices. Original magnification was ϫ 50 for A and C, and ϫ 25 for B.
fection. Equal amounts of membrane protein from two preparations (cells transfected with CaR-Flag plus cells transfected with one of the EGFP-tagged receptors) were mixed, and CaRFlag was immunoprecipitated. Western blots of the immunoprecipitates were probed with the anti-GFP antibody. Illustrated in Fig. 3A (right panel) are the results, comparing CaRFlag plus CaR-EGFP (C:C) or CaR-Flag plus mGluR1␣-EGFP (G1:C) coexpressed in the same cells, and CaR-Flag and mGluR1␣-EGFP expressed in different cells and mixed prior to immunoprecipitation (G1/C). When membranes of individually transfected cells were mixed prior to immunoprecipitation, no GFP immunoreactivity was observed. (Similar results were obtained with C/G5 and C/B2, data not shown.) These results suggest that the differentially epitope-tagged receptors must be expressed in the same cells for co-precipitation, and presumably heterodimerization, to occur.
To determine whether the interaction between CaR and Group I mGluRs was stabilized via a covalent disulfide linkage, as is observed for CaR:CaR or mGluR:mGluR homodimers (26, 28) , membranes isolated from HEK-293 cells co-transfected with CaR-Flag and CaR-EGFP (C:C) or CaR-Flag and mGluR1␣-EGFP (G:C) were immunoprecipitated with antiFlag antibody, and then solubilized and electrophoresed in the absence or presence of ␤-mercaptoethanol. The Western blot in Fig. 3B illustrates that in the absence of ␤-mercaptoethanol, GFP immunoreactivity appears predominantly at a molecular weight consistent with CaR-Flag:CaR-EGFP or CaR-Flag: mGluR1-EGFP dimers (and higher oligomers), while in the presence of ␤-mercaptoethanol, the preponderance of GFP immunoreactivity is present at a molecular weight consistent with the respective monomers. These results strongly suggest that CaR:mGluR heterodimers are stabilized by covalent disulfide bonds, as has been demonstrated for the respective homodimers.
Altered Surface Expression of CaR:mGluR1␣ Heterodimers in the Presence of Homer 1c-CaR
mutants which are misfolded or incorrectly dimerized are not fully glycosylated and do not traffic to the plasma membrane (33, 38, 39) . Western blots derived from immunoprecipitation of CaR-Flag plus Group I mGluRs exhibit predominantly the fully glycosylated forms of both CaR and mGluR1␣ or mGluR5 (Fig. 3A) , suggesting complete processing of the heterodimers and localization to the plasma membrane. As a second test of plasma membrane localization of the CaR/mGluR heterodimers, we took advantage of the family of Homer/vesl proteins which interact with and specify subcellular localization of Group I mGluRs (40) . In particular, Homer 1c has been shown both in vivo (41) and in vitro (42) to stabilize Group I mGluRs at the plasma membrane.
An ELISA was used to quantify plasma membrane localization of CaR:CaR and mGluR1␣:mGluR1␣ homodimers, as well as CaR:mGluR1␣ heterodimers; in each transfection, the first partner in the pair contained an amino-terminal Flag epitope. Coexpression of Flag-mGluR1␣ plus Homer 1c in HEK-293 cells resulted in a significant increase in plasma membrane localization of Flag-mGluR1␣, when compared with FlagmGluR1␣ alone (Fig. 4A) , as has been previously shown (42) . CaR does not contain the -PPSPFR-epitope, present near the carboxyl terminus of Group I mGluRs, which is required for interaction with the Homer EVH1 domain (69) . In confirmation, the degree of plasma membrane localization of Flag-CaR in HEK-293 cells was not affected by coexpression with Homer 1c (Fig. 4B) . However, when Flag-CaR plus mGluR1␣ were coexpressed, Homer 1c significantly increased the amount of plasma membrane-localized Flag-CaR (Fig. 4B) . These results suggest that localization of Flag-CaR:mGluR1␣ heterodimers at the plasma membrane is stabilized in the presence of Homer 1c. In addition, the results imply that only a single -PPSPFRepitope is required within the receptor dimer for Homer 1c-mediated enhancement of plasma membrane localization, since the increase in plasma membrane localization of the FlagmGluR1␣:mGluR1␣ dimers is comparable to that observed for the Flag-CaR:mGluR1␣ heterodimers (compare Fig. 4, A and  B) . Coexpression of Flag-CaR with mGluR5 significantly in- creased Flag-CaR at the plasma membrane in both the absence and presence of Homer 1c (Fig. 4C) .
Internalization of CaR:mGluR1␣ Heterodimers in Response to Both Ca
2ϩ and Glutamate-Coexpression of CaR and mGluR1␣ with Homer 1c increases CaR localization to the plasma membrane, presumably within the CaR:mGluR1␣ heterodimer (Fig. 4B) . Conversely, decreases in plasma membrane localization occur as a result of agonist exposure for many GPCRs; therefore the effects of Ca 2ϩ or glutamate were examined in cells expressing Flag-CaR:CaR, Flag-mGluR1␣: mGluR1␣, Flag-CaR:mGluR1␣, or Flag-mGluR1␣:CaR dimers. For each transfection pair, plasma membrane localization of the Flag-tagged receptor was determined by ELISA. Transfected cells were exposed to either control (0.5 mM Ca 2ϩ , no glutamate), 10 mM Ca 2ϩ , 1 mM glutamate, or 10 mM Ca 2ϩ plus 1 mM glutamate, for 15 min. The results are illustrated in Fig. 5 .
Cells expressing Flag-CaR:CaR (Fig. 5A ) responded to 10 mM Ca 2ϩ with a 57% decrease in plasma membrane localization of receptor dimers, but 1 mM glutamate had no statistically significant effect. The response to both 10 mM Ca 2ϩ plus 1 mM glutamate was indistinguishable from the response to Ca 2ϩ alone. Internalization of Flag-CaR:mGluR1␣ heterodimers was sensitive to either 10 mM Ca 2ϩ or 1 mM glutamate to a similar extent, while there was no further potentiation of internalization when both agonists were added together (Fig. 5B) . These results indicate that heterodimerization of CaR with mGluR1␣ confers glutamate sensitivity to CaR internalization.
Cells expressing Flag-mGluR1␣:mGluR1␣ (Fig. 5C ) responded to 1 mM glutamate with a 57% decrease in plasma membrane-localized receptor dimers, while 10 mM Ca 2ϩ induced a 39% decrease. mGluR1␣ activation can be induced by either Ca 2ϩ or glutamate (19, 20) , and these results demonstrate that Ca 2ϩ can also induce mGluR1␣ internalization. Both 10 mM Ca 2ϩ and 1 mM glutamate added together had an effect comparable to that of 1 mM glutamate (59% decrease). Cells expressing Flag-mGluR1␣:CaR exhibited a statistically significant increase in response to 10 mM Ca 2ϩ (39.4% in the homodimer versus 62% reduction in the heterodimer, p Ͻ 0.01). The Flag-mGluR1␣:CaR heterodimer was equally sensitive to each agonist alone or both agonists added simultaneously. Results from both Flag-CaR:mGluR1␣ or Flag-mGluR1␣:CaR heterodimers indicate an increased sensitivity to desensitization, i.e. internalization, in response to exposure to the agonist which activates the non-tagged heterodimer partner.
DISCUSSION
As early as the 1980s, oligomers of ␤ 2 -adrenergic receptor (43) and muscarinic receptors (44) were observed, but their functional significance was uncertain. More recently, oligomerization has been suggested to account for the multiple agonist affinity states observed for GPCRs (45, 46) . Convincing functional evidence for ␤ 2 -adrenergic receptor dimerization is derived from complementation studies, where wild type receptors exert a dominant positive effect on mutant receptors (47) or coexpression of two deficient mutants or chimeras restores receptor function (48, 49) . Dimerization of ␤ 2 -adrenergic receptor is required for efficient signaling via G s (50) . Internalization of ␦-opioid receptors depends upon agonist-induced conversion of receptor dimers to monomers, a process which is sensitive to agonist structure (51) .
Heterodimerization has been observed between subtypes of somatostatin (52) and opioid receptors (53, 54) , and is required for formation of functional GABA B receptors (29 -31) . Receptors belonging to distinct families, i.e. the angiotensin II receptor AT 1 and bradykinin receptor B 2 (55) , the dopamine D 1 and adenosine A 1 receptors (56), and mGluR1␣ and adenosine A1 receptors (57) have recently been shown to heterodimerize. Heterodimerization among subtypes of a single class or among multiple classes of GPCRs can lead to signal enhancement, altered agonist sensitivities, and/or differences in trafficking or desensitization pathways.
In the present study, covalent heterodimerization of CaR and Group I mGluRs has been demonstrated both in vivo and in HEK-293 cells. In particular, immunoprecipitation of CaR from bovine brain resulted in co-precipitation of mGluR1␣. In rat brain, CaR and mGluR1␣ were co-localized throughout the hippocampus and cerebellum, suggesting the potential for heterodimerization. In transfected HEK-293 cells, CaR and either mGluR1␣ or mGluR5 were co-precipitated when expressed in the same cells, but not when membranes expressing the two types of receptors were mixed prior to immunoprecipitation. In both types of heterologous expression experiments, CaR did not co-precipitate with ␤ 2 -adrenergic receptor, a receptor from a distinct GPCR family.
CaR:mGluR1␣ heterodimers are sensitive to reducing agents such as ␤-mercaptoethanol. While sensitivity to reducing agents does not necessarily imply covalent heterodimerization, both mGluR and CaR homodimers are stabilized by disulfide bonds. The cysteine residue responsible for homodimerization of mGluRs, C140 (58) , is localized to an unstructured loop in the ligand binding 1 domain of the recently determined crystal structure of mGluR1 (59) . Cysteine residues within the mGluR and CaR extracellular domains are highly conserved. CaR Cys 129 , corresponding to Cys 140 of mGluR1␣, is responsible for CaR homodimerization (27) . Although covalent disulfide linkages between mGluR1␣ and CaR remain to be confirmed, and the particular residues involved identified, it seems likely that homo-and heterodimerization may be mediated via the same cysteine residues, as well as the cryptic dimer interface defined by the B helix of ligand binding 1, which exhibits 42% identity and 67% homology between Group I mGluRs and CaR (59) . Group I mGluRs are preferentially localized to the periphery of the postsynaptic densities of type I synapses in the hippocampus and cerebellum (18, 60) . Targeting and trafficking of Group I mGluRs is dynamically modulated by Homer/vesl proteins (61) . Proteins in the Homer/vesl family bind to prolinerich sequences in Group I mGluRs, inositol trisphosphate and ryanodine receptors, and Shank proteins (40) and function as PDZ-like adaptor proteins to assemble signaling complexes. All Homer/vesl proteins contain self-association domains except Homer 1a, which is an early response gene and acts as a dominant negative to disrupt stable Homer/vesl protein-containing complexes (61, 62) . Homer 1a dynamically regulates coupling of Group I mGluRs to ion channels (M-type potassium channels and N-type calcium channels) and intracellular Ca 2ϩ signaling (63) . Given the perisynaptic localization of Group I mGluRs and their role(s) in activity dependent plasticity, it is interesting to speculate on the potential contribution(s) of CaR at the same cellular location, particularly in light of the demonstration of Homer 1c-mediated trafficking of CaR:mGluR heterodimers. The peak concentration of glutamate and its time course of clearance from the synaptic cleft is dependent on the level of presynaptic activity (64) . High levels of presynaptic activity are required to elicit significant activation of Group I mGluRs, given their perisynaptic localization. Under these same conditions, simulations have predicted significant decreases in extracellular Ca 2ϩ in the synaptic cleft (65) . Decreases in Ca 2ϩ within the synaptic cleft have also been inferred from alterations in the sizes of pre-and postsynaptic currents (66, 67) . It is unclear, however, how these rapid, dynamic changes in Ca 2ϩ within the synaptic cleft would affect CaR, since modeling studies suggest that depletion develops within the duration of an action potential, and recovery occurs within 2 ms (68). It is most likely that CaR would respond to the time-averaged Ca 2ϩ concentration within the synaptic cleft at varying levels of synaptic activity. In the context of high levels of synaptic activity, the decrease in cleft Ca 2ϩ and the attendant decreases in CaR activity may limit the postsynaptic consequences of mGluR activation. In vivo studies will be required to adequately address this issue.
Heterodimerization of CaR with mGluRs raises many questions with respect to the role(s) for CaR in brain. Do CaR homodimers and CaR:mGluR heterodimers subserve different functions, or does heterodimerization permit differential subcellular localization of CaR without a change in receptor function? How is heterodimerization regulated, and how is the balance of homo-and heterodimerization of CaR and mGluRs maintained? Does diversity with respect to CaR localization and function in other tissues, including parathyroid, kidney, and intestine, result from CaR heterodimerization with as yet unidentified partners?
